OR WAIT null SECS
© 2023 MJH Life Sciences and Consultant Live. All rights reserved.
February 03, 2023
Drs Diana Isaacs and Natalie Bellini discuss the everyday challenges of managing type 1 diabetes and underscore the need for new treatments to improve the quality of life for people living with type 1 diabetes
Expert healthcare practitioners discuss the potential of CGM and other technology to identify signs of type 1 diabetes.
Dr Emily Sims reviews the study design of the clinical trials with teplizumab and shares key findings from the completed phase 2 trial.
Dr Emily Sims provides an overview of the stages of type 1 diabetes (T1D) and explains how teplizumab slows the immune-mediated destruction of beta cells.